..., instructions or products referred to in the content or advertisements. 2024 Low-grade adenosquamous carcinoma Metaplastic carcinoma Breast cancer Cystic lesion Case report Low-grade adenosquamous carcinoma (LGASC) of the breast is an uncommon type of carcinoma. It is categorized...

...Maria Rosaria Valerio; Vittorio Gebbia; Dario Piazza; Giuseppina Campisi; Eleonora D’Agati; Monica Bazzano Introduction: Metastatic breast cancer (MBC) presents an enduring and significant challenge for affected women, requiring sustained commitment over the years. Case Presentation: This paper...

...Hitomi Matsuki; Shoji Oura Introduction: Nipple retraction has long been regarded as an absolute contraindication factor for nipple preservation in breast cancer surgery. Case Presentation: A 62-year-old woman was referred to our hospital for the treatment of breast cancer with slight nipple...

...Kazuki Asazuma; Akihiko Shimomura; Yukino Kawamura; Tomoko Taniyama; Chikako Shimizu Introduction: Breast cancer is the second most common cause of central nervous system (CNS) metastases. It has been shown that the median time from breast cancer diagnosis to CNS metastasis is 30.9 months...

...Kabsoo Shin; Ryul Kim; Hansol Park; Wonchul Lee; Sangmoon Lee; Joonoh Im; Ji Eun Lee; Sung Hun Kim; Erin Connolly-Strong; Young Seok Ju; Brian Baek-Lok Oh; Jeongmin Lee Introduction: Breast cancer exhibits vast genomic diversity, leading to varied clinical manifestations. Integrating molecular...

...Camellia Akhgarjand; Aliarash Anoushirvani; Aryan Tavakoli; Mahmoud Dehghani Ghorbi Introduction: The incidence of second malignancies in breast cancer survivors has increased because of early detection and improved cancer treatment modalities. The synchronous occurrence of chronic lymphocytic...

..., instructions or products referred to in the content or advertisements. 2024 Spindle cell carcinoma Breast cancer Case report Phyllodes tumor Spindle cell sarcomas are rare lesions of the breast which range from benign to high-grade malignant carcinomas, with a prevalence of less than 0.5% per...

...Shoko Sato; Sae Imada; Ryosuke Hayami; Kazumori Arai; Rieko Kosugi; Michiko Tsuneizumi; Ryoichi Matsunuma Introduction: Managing breast cancer in female-to-male (FtM) transgender patients is complicated and challenging. Androgens play a crucial role in the development of secondary sexual identity...

... for estrogen receptor, progesterone receptor, and HER2. HER2-positive MBC is therefore extremely rare. Most MBCs have poor response to chemotherapy. HER2-targeted neoadjuvant chemotherapy (NAC) is widely performed and has high efficacy in treating HER2-positive breast cancer. We report an atypical case of HER2...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Atezolizumab Breast cancer Cystoid macular edema Nanoparticle albumin-bound paclitaxel Recently...

... of many different cancer types, but its combination with other anti-cancer therapy is not well understood. We report a case of a 66-year-old woman who presented with triple-negative breast cancer, multifocal hormone receptor-positive breast cancer, primary epidermal growth factor receptor-mutated lung...

...Yujing J. Heng; Kevin J. Zhang; Monica G. Valero; Gabrielle M. Baker; Valerie J. Fein-Zachary; Michael S. Irwig; Gerburg M. Wulf There is limited literature about breast cancer in the transgender population. Very little is known about how gender-affirming hormone therapy affects their breast cancer...

...Maho Sugino; Yoshiya Horimoto; Fumi Murakami; Yuka Takahashi; Kazutomo Ouchi; Hideaki Sato; Yasunori Ishido Encapsulated papillary carcinoma (EPC) is a relatively rare histologic type of breast cancer. It is sometimes difficult to obtain a definitive diagnosis by needle biopsy, reflecting its...

...Sherif Mostafa; Mhd Baraa Habib; Nada Ahmed; Bisher Sawaf; Nagham Sadik; Ahmed M. Abdalhadi Breast cancer is the most prevalent cancer in women worldwide, and its prevalence has increased since the introduction of screening programs. Most cases are discovered at an early stage; however, despite...

...Toko Kumeta; Kei Yamaguchi; Ryosuke Hayami; Kazumori Arai; Michiko Tsuneizumi; Ryoichi Matsunuma Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with higher rates of relapse and mortality compared to other subtypes. Chemotherapy has been a mainstream...

...Chiaki Matsui; Nobuhiro Shibata; Chie Hirai; Manami Tada; Yuichiro Kikawa; Tomoharu Sugie In recent years, both the number of patients with breast cancer and those with associated brain metastases (BMs) have increased. Human epidermal growth factor receptor 2 (HER2)-positive breast cancer has...

...Erika Barbieri; Giulia Caraceni; Damiano Gentile; Francesca Gavazzi; Alessandro Zerbi; Corrado Tinterri Gastrointestinal tract breast cancer (BC) metastases represent a rare event and generally originate from the lobular subtype. Duodenal involvement was rarely described in previous case series...

...Miriam Hussein; Anders Bonde Jensen Chemotherapy is widely used in cancer treatment, and the drug Capecitabine is often used in treatment of breast cancer and usually well-tolerated. Toxicity from Capecitabine typically involves hand-foot syndrome, fatigue, nausea, reduced appetite, and diarrhea...

... to spread worldwide with the development of highly transmissible strains. Several guidelines addressing management of cancer patients during the COVID-19 pandemic have been published, primarily based upon expert opinion. The COVID-19 pandemic has affected all aspects of breast cancer care including...

... the human epidermal growth factor receptor type 2 (HER2)-positive breast cancer with no distant metastasis, anti-HER2 agents-containing chemotherapy brought about clinical complete response of the locally advanced breast cancer with a shrunken but still large skin defect. We, therefore, treated the patient...